$MNOV

$1.40▲ 6.87% YTD

7 SEC 13D/G filings tracked · Last updated Oct 30, 2026

Filing History

MNOV - MediciNova, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks Simplified

$1.40▲ 6.87%Oct 30, 2026 · ThinkSabio Blog

$MNOV SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MNOV MediciNova, Inc. : $1.40 Sector: Healthcare | YTD: 🔼+ 6.87…

News

MNOV ▼ -11.8% - MediciNova, Inc.

CP $1.35▲ -11.8%Oct 12, 2026 · ThinkSabio Blog

$MNOV - MediciNova CEO Provides Shareholder Update…

News

MNOV ▲ +0.6% - MediciNova, Inc.

CP $1.76▲ +0.6%Oct 6, 2026 · ThinkSabio Blog

$MNOV - MediciNova to Participate in the Maxim Growth Summit…

SEC 13D/G

MNOV - MediciNova, Inc. - SEC Filing Update (29-SEP-2026) | ThinkSabio - Stocks Simplified

$1.92▲ 46.56%Sep 29, 2026 · ThinkSabio Blog

$MNOV SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MNOV MediciNova, Inc. : $1.92 Sector: Healthcare | YTD: 🔼+ 46.5…

News

MNOV ▼ -31.5% - MediciNova, Inc.

CP $1.76▲ -31.5%Sep 28, 2026 · ThinkSabio Blog

$MNOV - MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)…

News

MNOV ▼ -6.4% - MediciNova, Inc.

CP $2.63▲ -6.4%Sep 24, 2026 · ThinkSabio Blog

$MNOV Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast) Topline da…

News

MNOV ▼ -6.4% - MediciNova, Inc.

CP $2.63▲ -6.4%Sep 24, 2026 · ThinkSabio Blog

$MNOV - MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilas…